Via Reuters: A combination of two anti-viral drugs developed by Bristol-Myers Squibb Co cured 90 percent of previously untreated hepatitis C patients and 82 percent of those who failed to respond to prior therapy, according to results from a late stage study presented on Thursday. The Phase III trial of more than 700 patients called Hallmark-Dual tested a combination of …
Read More »Tag Archives: Hep C
FDA Approves New Hep C Drug
Via press release from the CDC: Today, the FDA approved an important new treatment for chronic hepatitis C. The drug, sofosbuvir, is a major advance in the treatment of a disease that affects approximately 3 million Americans and causes more than 15,000 deaths in the U.S. annually. Today marks a landmark advance in the treatment of hepatitis C, opening up …
Read More »